Today German GDP figure was released, which showed German economy grew 0.3% in third quarter, up 1.8% from a year ago.
While the growth figure is much better than 1.6% y/y in second quarter and 1.1% in the first, a closer look reveals thanks go to migrants and German consumers.
- To provide migrants places to stay and to provide them jobs, government has been spending billions of Dollar that has boosted overall GDP.
- Final consumption expenditure growth came at 0.6% q/q, highest since fourth quarter last year.
- Government expenditure rose by 1.3% from previous quarter and up by 2.9% from a year ago, which is fastest rise in expenditure since the 2008/09 crisis.
While overall consumption remained robust, other elements have not been much of a show
- Export growth was much weaker, growing at just 0.2%. Without weaker Euro, it could have been worse.
- Investment remains weak, with gross capital formation shrank for second consecutive quarter, -0.4% in second quarter and -0.3% in third.
Looking at the detailed German GDP, it seems ECB is right in bringing out further stimulus as emerging market weakness is taking toll in Germany as well as larger Europe.


JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Thailand Inflation Remains Negative for 10th Straight Month in January
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns




